United States Biotechnology & Medical Research

Synthorx Inc (THOR)

Track

Track

Ticker: THOR Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
RA CAPITAL MANAGEMENT, LLC Large shareholder
Transaction date
Purchase
Price
230.17
Quantity 5,298 -14.6%
Value US$1,514,349
Kolchinsky Peter Non-Executive Director Large shareholder
Transaction date
Purchase
Price
263.71
Quantity 90,248 -23.4%
Value US$4,377,109
ORBIMED ADVISORS LLC Non-Executive Director Large shareholder
Transaction date
Purchase
Price
256.02
Quantity 26,557 +7.8%
Value US$3,974,782
Thompson Peter A. Non-Executive Director Large shareholder
Transaction date
Purchase
Price
11.00
Quantity 1,363,636 +34.5%
Value US$14,999,996
Reardon Tighe Acting Chief Financial Officer Officer
Transaction date
Purchase
Price
11.00
Quantity 545,455 +48.0%
Value US$6,000,005
Lichter Jay Non-Executive Director Large shareholder
Transaction date
Purchase
Price
11.00
Quantity 545,455 +48.0%
Value US$6,000,005
Avalon Ventures X, L.P. Large shareholder
Transaction date
Purchase
Price
11.00
Quantity 545,455 +48.0%
Value US$6,000,005
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2018-12-13 2018-12-11 B Purchase RA CAPITAL MANAGEMENT, LLC Large shareholder
5,298 -14.6%
230.17
US$1,514,349 		5,298 -14.6% 230.17 US$1,514,349
2018-12-13 2018-12-11 B Purchase Kolchinsky Peter Non-Executive Director Large shareholder
90,248 -23.4%
263.71
US$4,377,109 		90,248 -23.4% 263.71 US$4,377,109
2018-12-13 2018-12-11 B Purchase ORBIMED ADVISORS LLC Non-Executive Director Large shareholder
26,557 +7.8%
256.02
US$3,974,782 		26,557 +7.8% 256.02 US$3,974,782
2018-12-13 2018-12-11 B Purchase Thompson Peter A. Non-Executive Director Large shareholder
1,363,636 +34.5%
11.00
US$14,999,996 		1,363,636 +34.5% 11.00 US$14,999,996
2018-12-13 2018-12-11 B Purchase Reardon Tighe

Acting Chief Financial Officer

Officer
545,455 +48.0%
11.00
US$6,000,005 		545,455 +48.0% 11.00 US$6,000,005
2018-12-13 2018-12-11 B Purchase Lichter Jay Non-Executive Director Large shareholder
545,455 +48.0%
11.00
US$6,000,005 		545,455 +48.0% 11.00 US$6,000,005
2018-12-13 2018-12-11 B Purchase Avalon Ventures X, L.P. Large shareholder
545,455 +48.0%
11.00
US$6,000,005 		545,455 +48.0% 11.00 US$6,000,005
Explore more

More insider trading research around Synthorx Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America